136 related articles for article (PubMed ID: 37863181)
1. Commentary: Watch and wait for disaster? Is it safe to watch and wait paraconduit hernias following esophagectomy?
Lagisetty K
J Thorac Cardiovasc Surg; 2024 May; 167(5):1641-1642. PubMed ID: 37863181
[No Abstract] [Full Text] [Related]
2. Discussion to: Paraconduit hernia following esophagectomy: Is it safe to watch and wait?
J Thorac Cardiovasc Surg; 2024 May; 167(5):1638-1640. PubMed ID: 38441516
[No Abstract] [Full Text] [Related]
3. [Management of local tumor recurrence within the watch and wait strategy in rectal cancer].
Germer CT; Reibetanz J
Chirurg; 2021 Feb; 92(2):170. PubMed ID: 33528628
[No Abstract] [Full Text] [Related]
4. ASO Author Reflections: Local Excision Following Neoadjuvant Therapy for Rectal Cancer: A Compromise Between TME and Watch-and-Wait in Patients with Major Response.
Bao QR; Capelli G; Spolverato G; Pucciarelli S
Ann Surg Oncol; 2021 May; 28(5):2809-2810. PubMed ID: 33095361
[No Abstract] [Full Text] [Related]
5. Watch and wait or surgery for clinical complete response in rectal cancer: a need to study both sides.
Parmar KL; Malcomson L; Renehan AG
Colorectal Dis; 2020 Jul; 22(7):839-840. PubMed ID: 31755201
[No Abstract] [Full Text] [Related]
6. [Rational evaluation of the complete response after neoadjuvant therapy in locally advanced mid-low rectal cancer: the pros and cons of "watch and wait" strategy].
Gu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):507-513. PubMed ID: 31238630
[TBL] [Abstract][Full Text] [Related]
7. ["Watch and wait" strategy after neoadjuvant therapy for rectal cancer: status survey of perceptions, attitudes and treatment selection in Chinese surgeons].
Sun TT; Wang L; Yao YF; Peng YF; Zhao J; Zhan TC; Leng JH; Wang HY; Chen N; Chen PJ; Li YJ; Zhang X; Liu XZ; Zhang Y; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):550-559. PubMed ID: 31238634
[No Abstract] [Full Text] [Related]
8. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.
Renehan AG; Malcomson L; Emsley R; Gollins S; Maw A; Myint AS; Rooney PS; Susnerwala S; Blower A; Saunders MP; Wilson MS; Scott N; O'Dwyer ST
Lancet Oncol; 2016 Feb; 17(2):174-183. PubMed ID: 26705854
[TBL] [Abstract][Full Text] [Related]
9. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis.
Dossa F; Chesney TR; Acuna SA; Baxter NN
Lancet Gastroenterol Hepatol; 2017 Jul; 2(7):501-513. PubMed ID: 28479372
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic rectal resection following regrowth of rectal cancer in a watch-and-wait programme - A video vignette.
Faidh Ramzee A; Mureb A; Al Dhaheri M; Qadir K; Abu Nada M; Parvaiz A
Colorectal Dis; 2022 Jan; 24(1):139. PubMed ID: 34553477
[No Abstract] [Full Text] [Related]
11. Watch-and-wait Management for Rectal Cancer After Clinical Complete Response to Neoadjuvant Therapy.
Yuval JB; Garcia-Aguilar J
Adv Surg; 2021 Sep; 55():89-107. PubMed ID: 34389102
[No Abstract] [Full Text] [Related]
12. Rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy, surgery, or "watch and wait".
Lai CL; Lai MJ; Wu CC; Jao SW; Hsiao CW
Int J Colorectal Dis; 2016 Feb; 31(2):413-9. PubMed ID: 26607907
[TBL] [Abstract][Full Text] [Related]
13. Watch and wait: staying the course?
Bergamaschi R; Bhatti S
Updates Surg; 2023 Sep; 75(6):1379-1381. PubMed ID: 37162638
[No Abstract] [Full Text] [Related]
14. Are All Patients Suitable for the Watch-and-Wait Approach After Clinical Complete Response?
Yüksel BC
Dis Colon Rectum; 2022 Oct; 65(10):e962. PubMed ID: 35671258
[No Abstract] [Full Text] [Related]
15. Patient and multidisciplinary team perspectives on watch and wait in rectal cancer.
Mohan H; Rabie M; Walsh C; Harji D; Sutton P; Geh I; Jackson I; Helbren E; Evans M; Jenkins JT
Colorectal Dis; 2023 Jul; 25(7):1489-1497. PubMed ID: 37477408
[TBL] [Abstract][Full Text] [Related]
16. Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study.
Fernandez LM; São Julião GP; Figueiredo NL; Beets GL; van der Valk MJM; Bahadoer RR; Hilling DE; Meershoek-Klein Kranenbarg E; Roodvoets AGH; Renehan AG; van de Velde CJH; Habr-Gama A; Perez RO;
Lancet Oncol; 2021 Jan; 22(1):43-50. PubMed ID: 33316218
[TBL] [Abstract][Full Text] [Related]
17. The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy.
Wang QX; Zhang R; Xiao WW; Zhang S; Wei MB; Li YH; Chang H; Xie WH; Li LR; Ding PR; Chen G; Zeng ZF; Wang WH; Wan XB; Gao YH
Radiat Oncol; 2021 Jan; 16(1):16. PubMed ID: 33468176
[TBL] [Abstract][Full Text] [Related]
18. Organ Preservation in Patients with Rectal Cancer Treated with Total Neoadjuvant Therapy.
Jimenez-Rodriguez RM; Quezada-Diaz F; Hameed I; Kalabin A; Patil S; Smith JJ; Garcia-Aguilar J
Dis Colon Rectum; 2021 Dec; 64(12):1463-1470. PubMed ID: 34508014
[TBL] [Abstract][Full Text] [Related]
19. Particular aspects of treating rectal cancer: The watch and wait approach.
Draghici DA; Stoian AR; Porojan VA; David OI; Bedereag Ş; Ciuhu AN; Haidar A; Creţoiu D; Condrat CE; Grigorean VT
J Cancer Res Ther; 2023; 19(2):461-469. PubMed ID: 37006080
[TBL] [Abstract][Full Text] [Related]
20. Is the Management of Rectal Cancer Using a Watch and Wait Approach Feasible, Safe and Effective in a Publicly Funded General Hospital?
Kaul S; Rao C; Mane R; Tan KL; Khan AHA; Hussain MS; Shafi MA; Buettner F; Banerjee S; Boulton R; Bhargava A; Huang J; Hanson M; Raouf S; Ball S; Rajendran N
Clin Oncol (R Coll Radiol); 2022 Jan; 34(1):e25-e34. PubMed ID: 34454807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]